Hideki Garren - Oct 3, 2022 Form 4 Insider Report for PROTHENA CORP PUBLIC LTD CO (PRTA)

Role
Chief Medical Officer
Signature
/s/ Michael Malecek, as attorney-in-fact for Hideki Garren
Stock symbol
PRTA
Transactions as of
Oct 3, 2022
Transactions value $
-$144,000
Form type
4
Date filed
10/5/2022, 09:46 PM
Previous filing
Sep 16, 2022
Next filing
Nov 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRTA Ordinary Shares, par value $0.01 per share Options Exercise $99.6K +4K $24.90 4K Oct 3, 2022 Direct
transaction PRTA Ordinary Shares, par value $0.01 per share Sale -$244K -4K -100% $60.90 0 Oct 3, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRTA Stock Option (Right to Buy) Options Exercise $0 -4K -1.71% $0.00 230K Oct 3, 2022 Ordinary Shares 4K $24.90 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on April 5, 2022 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.